Please find attached the disclosure under Reg 7(2) of the SEBI (Prohibition of Insider Trading) Reg 2015
HEALTHX · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
On the reaction day the stock moved 2.6 pts more than Nifty Microcap 250 and 1.8 pts more than its Healthcare Service Provider peers, over the same two closes: a difference in percentage points, not a measure of what the filing did.
Minute windows have no benchmark: there is no intraday index history to compare against.
Sastasundar Ventures Limited disclosed that its promoter, Mr. Banwari Lal Mittal, bought 20,000 equity shares of the company through a market purchase on 17 November 2025. The total value of the acquisition was approximately Rs. 59.85 lakh. Following this purchase, Mr. Mittal's shareholding increased marginally from 33.37% (1,06,16,000 shares) to 33.4355% (1,06,36,000 shares). No derivative trades were involved. The disclosure was filed under Regulation 7(2) of the SEBI (Prohibition of Insider Trading) Regulations, 2015.
This is a small but positive signal showing continued promoter confidence in the company, as the promoter is adding to his stake. However, the size of the purchase is very modest (about 0.07% increase in holding) and is unlikely to materially move the stock price on its own.